Skip to content
Companies

Nurocor

Software that digitizes clinical trial workflows

Raised to date

$375K

of $375K offered across 2 Form D filings

Investors
1
Last filed
Feb 28, 2025

About

Nurocor Inc. is a pioneering technology company that specializes in delivering digital solutions for the clinical trial development sector within the life sciences industry. Committed to transforming traditional clinical processes, Nurocor focuses on automating and digitizing workflows to enhance the efficiency and accuracy of clinical trials.

Nurocor differentiates itself by providing a robust platform that not only streamlines clinical trial operations but also fosters collaboration among teams through an integrated digital approach.

Funding

$250K round, first sold Oct 2024$250K sold20252026
Now
  • Option to acquireFiled Feb 28, 2025Form D
    $250K/ $250K
  • Option to acquireFiled Feb 28, 2025Form D
    $125K/ $125K

Product

Nurocor Clinical Platform (NCP)

Clinical Trial Software

The Nurocor Clinical Platform (NCP) is an advanced digital tool tailored for the clinical trial industry, designed to convert paper-based processes into efficient digital workflows. It streamlines the entire clinical lifecycle by automating essential activities and ensuring compliance with key data standards.

  • Digitalized protocol content that drives downstream automations
  • Parallelized workflows to accelerate trial lifecycles
  • Support for the creation of clinical development plans, target product profiles, and optimized program and study designs

Built for

Biopharmaceutical companies

People on file